Whalen Wealth Management Inc. purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,887 shares of the company's stock, valued at approximately $253,000.
Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the period. GAMMA Investing LLC grew its position in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after buying an additional 471 shares in the last quarter. Lindenwold Advisors INC increased its stake in Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company's stock valued at $299,000 after acquiring an additional 489 shares during the period. Sheets Smith Wealth Management raised its holdings in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock valued at $553,000 after acquiring an additional 550 shares in the last quarter. Finally, Trust Point Inc. lifted its position in shares of Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company's stock worth $755,000 after acquiring an additional 622 shares during the period. 98.05% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Option Care Health
In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm's stock in a transaction on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.64% of the company's stock.
Analysts Set New Price Targets
A number of brokerages recently commented on OPCH. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the company from $26.00 to $35.00 in a research note on Thursday. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price objective on the stock. Finally, JMP Securities reissued a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $31.14.
Get Our Latest Stock Report on OPCH
Option Care Health Price Performance
Shares of NASDAQ:OPCH traded up $0.69 during trading on Thursday, reaching $30.00. The stock had a trading volume of 2,273,287 shares, compared to its average volume of 2,346,244. The stock has a market capitalization of $5.11 billion, a PE ratio of 25.21, a P/E/G ratio of 2.12 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The business's 50-day moving average price is $24.10 and its 200 day moving average price is $27.78.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
